by Stephen Manobiano | Mar 14, 2026 | Commercialization, Insight, Sales
Selling into the life sciences requires a unique approach. Unlike traditional B2B sales, life science buyers are often scientists, researchers, or technical experts. Their purchasing decisions depend on: Data quality Technical validation Peer recommendations Because...
by Stephen Manobiano | Mar 12, 2026 | Commercialization, Fractional, Insight
Many biotech companies reach a stage where they need senior commercial leadership but cannot justify hiring a full-time executive. This is why fractional consultants and fractional executives are becoming increasingly popular. Fractional leaders provide: Strategic...
by Stephen Manobiano | Feb 13, 2026 | Commercialization, news, tradeshows
SLAS Boston is expensive. Booth space. Freight. Travel. Hotels. Sponsorships. Swag.For many life science companies, the total investment quietly creeps into six figures. The real question executives should be asking right now isn’t: “How was the show?” It’s: Did it...
by Stephen Manobiano | Nov 11, 2025 | business development, Commercialization, Fractional, Marketing, news, Sales
In the fast-paced world of life sciences, early-stage and growing companies often face a critical gap, not in innovation, but in leadership. They have strong scientific foundations, but lack the senior commercial expertise needed to turn potential into performance....
by Stephen Manobiano | Aug 5, 2025 | Case Study, Commercialization, customer story, omnichannel, Sales
What happens when breakthrough epigenetics technology meets commercial urgency? This case study reveals how a promising academic startup with cutting-edge bisulfite and methylation sequencing IP, transformed into a revenue-ready organization in record time. PSG Life...
